<DOC>
	<DOCNO>NCT02857556</DOCNO>
	<brief_summary>The principal objective study qualify marker oxidative stress inflammatory cell ( monocyte ) patient stage 3 kidney failure ( diabetic ) , patient end-stage kidney failure ( diabetic ) , require dialysis . The evaluation marker do activation localization protein implicate vascular tone oxidative stress monocyte , correlate distribution cholesterol sphingomyelin within planar raft caveolae . The aim describe evolution treatment , could lead interventional study .</brief_summary>
	<brief_title>Potential Biomarkers Severity Endothelial Damage End-stage Chronic Kidney Failure</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Patient inform research Patients national health insurance cover Patients age 18 75 year Patients stage 3 kidney failure ( 30 ml/min &lt; cl creat &lt; 59 ml/min ) diabetic Patients stage 5 kidney failure ( cl creat &lt; 15 ml/mn ) diabetic require dialysis . Patients guardianship Pregnant breastfeed woman Infection ( include peritonitis peritoneal dialysis , infection catheter insertion site ) , Neoplastic disease , Systemic diseases flare , Patients positive Human Immunodeficience Virus ( HIV ) , Patients immunosuppressant Patients take antioxidant ( selenium , vitamin C and/or E ) Patient statin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>